Dabur India Ltd

The company attributed the expected growth to resilient domestic demand and sequential improvement across businesses despite geopolitical challenges and inflationary pressures in key markets. The company said its India FMCG business maintained growth momentum during the quarter, with rural demand continuing to outpace urban markets. It expects the domestic FMCG business to post near double-digit growth. The Home and Personal Care business is expected to grow at a near-teen rate. Hair oils and shampoos are likely to deliver high-teen growth, while oral care is expected to post near double-digit growth. Dabur said brands including the Herbal franchise, Meswak, Red Toothpaste and Lal Dant Manjan recorded broad-based growth. The healthcare business is expected to record mid-single-digit growth with sequential improvement. Flagship brands such as Hajmola, Pudin Hara, the Health Juices range, Dabur Honitus and Isabgol are expected to post robust double-digit growth. Dabur Glucose also recovered sequentially after being impacted during the early part of the quarter. The food business continued to record high double-digit growth, led by Badshah, while the beverage portfolio recovered sequentially on the back of strong growth in the Real Activ Juices range and Coconut Water. Emerging channels, including e-commerce, quick commerce and modern trade, are expected to post strong double-digit growth. Rural markets continued to outperform urban markets. Dabur's international business is expected to post high-teen growth in rupee terms despite headwinds in the Middle East. Markets including Egypt, Turkey, Bangladesh and the UK recorded strong double-digit growth. The company said elevated inflation, particularly in the haircare segment, was mitigated through calibrated price increases, helping maintain stable operating margins. It added that the business fundamentals remain strong and it remains focused on improving consumption, enhancing cost competitiveness, strengthening digital capabilities and delivering sustainable, profitable growth over the medium to long term. Dabur India is one of India's leading FMCG companies. Its India's FMCG portfolio includes power brands like Dabur Chyawanprash, Dabur Honey, Honitus, PudinHara and Dabur Lal Tail in the healthcare space; Dabur Amla and Dabur Red Paste in the personal care category; and real in the food & beverages space. The company reported 15.14% jump in consolidated net profit to Rs 368.60 crore on 7.35% increase in revenue from operations to Rs 3038.02 crore in Q4 FY26 over Q4 FY25. Shares of Dabur India fell 0.60% to settle at Rs 444.05 on Friday, 3 July 2026. Powered by Capital Market - Live

Dabur India will hold a meeting of the Board of Directors of the Company on 29 July 2026.

Dabur India Ltd is down for a fifth straight session today. The stock is quoting at Rs 420.4, down 0.44% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.75% on the day, quoting at 23923.15. The Sensex is at 76581.64, down 0.66%.Dabur India Ltd has lost around 5.99% in last one month.Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has eased around 2.06% in last one month and is currently quoting at 49355.1, down 0.47% on the day. The volume in the stock stood at 9.53 lakh shares today, compared to the daily average of 23.44 lakh shares in last one month. The benchmark June futures contract for the stock is quoting at Rs 421.35, down 0.55% on the day. Dabur India Ltd tumbled 11.51% in last one year as compared to a 4.48% slide in NIFTY and a 9.61% fall in the Nifty FMCG index.The PE of the stock is 49.86 based on TTM earnings ending March 26.Powered by Capital Market - Live

The company said the US FDA had conducted an inspection at the plant and issued inspectional observations, to which it had submitted responses. Following a review of the company's responses and the Establishment Inspection Report (EIR), the regulator issued the import alert on June 10, 2026. Dabur clarified that the order pertains only to a small section of the Silvassa manufacturing facility involved in private-label products and has no material impact on the company's financials, operations or other business activities. The affected products generate insignificant revenue for the company, it added. The company said its domestic products are not covered by the import alert and the Silvassa plant continues to operate normally. Dabur added that it is engaging with the US FDA through corrective and preventive action plans to address the identified gaps. The company also said multiple internal and independent third-party tests have not identified any out-of-specification issues or other concerns with its products. The FMCG major said it is implementing alternate sourcing strategies for its US customers while continuing to focus on product quality and consumer safety. Dabur India is one of India's leading FMCG companies. The company manufactures personal care, healthcare and food products. Its portfolio includes eight major power brands- Dabur Chyawanprash, Dabur Honey, Honitus, PudinHara and Dabur Lal Tail in the healthcare catrogory, Dabur Amla and Dabur Red Paste in the personal care and Real in the food & beverages space. The company reported 15.14% jump in consolidated net profit to Rs 368.60 crore on 7.35% increase in revenue from operations to Rs 3038.02 crore in Q4 FY26 over Q4 FY25. Shares of Dabur India rose 0.44% to Rs 424.05 on the BSE. Powered by Capital Market - Live

Dabur India has allotted 2,62,216 equity shares under ESOS on 28 May 2026. With this allotment, the paid up equity share capital has increased to Rs. 177,39,52,388/ divided into 177,39,52,388 equity shares of Re. 1/- each.

Profit before tax (PBT) jumped 15% YoY to Rs 473.68 crore in the quarter ended 31st March 2026. EBITDA (including other income) stood at Rs 636.9 crore, up 12.1% compared with Rs 568 crore recorded in Q4 FY25. Margin improved 90 bps to 21% in Q4 FY26 as against 20.1% in Q4 FY25. The India FMCG Business posted a growth of 9.5% during the quarter while operating profit from the segment rose 12.5% during the quarter, supported by strong execution in the domestic FMCG business and underlying volume growth of 6%. The company's hair care portfolio grew by about 27% during the quarter, led by the hair oils business which reported a 28% growth. The home care business posted an over 24% growth, while the digestives business expanded around 15% in Q4 FY26. The skin & salon business grew by over 12% while the toothpaste category rose over 7%. The OTC & ethicals business also registered around 7% growth. The Badshah portfolio recorded 12% growth during the quarter. Mohit Malhotra, global chief executive officer, Dabur India, said: 'despite inflationary pressures, Dabur leveraged its strong brand superiority to deliver healthy growth across the key and highly competitive home & personal care and healthcare categories. The company's business fundamentals remain robust, with brands across honey, health juices, digestives, oral care, hair care, healthcare, air fresheners, and foods reporting strong gains during the quarter. On international front, the company's international business grew by 2.5% during the quarter despite facing headwinds in Middle East. Growth was driven by Sub-Saharan Africa (20%), UK Namaste US (6.2%) and Bangladesh (22%). On an annual basis, the company's consolidated net profit rose 7.21% to Rs 1,895.03 crore on 5.01% rise in revenue from operations to Rs 13,192.57 crore in FY26 over FY25. Mohit Malhotra, said, 'In the fourth quarter, rural markets continued to outpace urban consumption with rural demand growing ahead of urban India by 350bps. That said, the gap between rural and urban growth has narrowed significantly compared to December 2025, reflecting a more balanced consumption recovery. We expect this convergence to continue. Within Urban India, e-commerce and Modern Trade have been driving demand, growing by 49% and 19% respectively. Quick Commerce is driving the online business, posting a growth of 54%. This channel was a major contributor to our foods business, which grew by 30% in Q4. We will continue to double down on emerging channels, which serve as the incubators for Dabur's innovation and premium products. As part of this initiative, we have launched SIENS, Dabur's first online only Direct-to-Consumer nutraceutical brand, which is showing great consumer traction. We continue to invest heavily behind this brand,' Meanwhile, the company's board recommended a final dividend of Rs 5.50 per equity share having face value of Re 1 each for the financial year 2025-26. The record date has been fixed as July 17 2026. Dabur India is one of India's leading FMCG companies. The company manufactures personal care, healthcare and food products. Its portfolio includes eight major power brands- Dabur Chyawanprash, Dabur Honey, Honitus, PudinHara and Dabur Lal Tail in the healthcare catrogory, Dabur Amla and Dabur Red Paste in the personal care and Real in the food & beverages space.Powered by Capital Market - Live

Dabur India Ltd rose for a fifth straight session today. The stock is quoting at Rs 487.55, up 3.73% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.67% on the day, quoting at 24164.3. The Sensex is at 77254.26, down 0.76%. Dabur India Ltd has added around 13.54% in last one month. Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has added around 7.42% in last one month and is currently quoting at 51068.45, up 0.21% on the day. The volume in the stock stood at 97.11 lakh shares today, compared to the daily average of 21.63 lakh shares in last one month. The benchmark May futures contract for the stock is quoting at Rs 489.5, up 3.92% on the day. Dabur India Ltd is up 5.36% in last one year as compared to a 0.65% gain in NIFTY and a 8.01% gain in the Nifty FMCG index.The PE of the stock is 57.18 based on TTM earnings ending December 25.Powered by Capital Market - Live

Net profit of Dabur India rose 15.14% to Rs 368.60 crore in the quarter ended March 2026 as against Rs 320.13 crore during the previous quarter ended March 2025. Sales rose 7.35% to Rs 3038.02 crore in the quarter ended March 2026 as against Rs 2830.14 crore during the previous quarter ended March 2025. For the full year,net profit rose 7.21% to Rs 1895.03 crore in the year ended March 2026 as against Rs 1767.63 crore during the previous year ended March 2025. Sales rose 5.01% to Rs 13192.57 crore in the year ended March 2026 as against Rs 12563.09 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales3038.022830.14 7 13192.5712563.09 5 OPM %15.1715.08 -18.5718.44 - PBDT595.88528.78 13 2904.412703.49 7 PBT473.68411.91 15 2435.482257.89 8 NP368.60320.13 15 1895.031767.63 7 Powered by Capital Market - Live

Profit before tax (PBT) jumped 15% YoY to Rs 473.68 crore in the quarter ended 31st March 2026. The India FMCG Business posted a growth of 9.5% during the quarter while operating profit from the segment rose 12.5% during the quarter, supported by strong execution in the domestic FMCG business and underlying volume growth of 6%. The company's hair care portfolio grew by about 27% during the quarter, led by the hair oils business which reported a 28% growth. The home care business posted an over 24% growth, while the digestives business expanded around 15% in Q4 FY26. The skin & salon business grew by over 12% while the toothpaste category rose over 7%. The OTC & ethicals business also registered around 7% growth. The Badshah portfolio recorded 12% growth during the quarter. Mohit Malhotra, global chief executive officer, Dabur India, said: 'despite inflationary pressures, Dabur leveraged its strong brand superiority to deliver healthy growth across the key and highly competitive home & personal care and healthcare categories. The company's business fundamentals remain robust, with brands across honey, health juices, digestives, oral care, hair care, healthcare, air fresheners, and foods reporting strong gains during the quarter. On international front, the company's international business grew by 2.5% during the quarter despite facing headwinds in Middle East. Growth was driven by Sub-Saharan Africa (20%), UK Namaste US (6.2%) and Bangladesh (22%). On an annual basis, the company's consolidated net profit rose 7.21% to Rs 1,895.03 crore on 5.01% rise in revenue from operations to Rs 13,192.57 crore in FY26 over FY25. Mohit Malhotra, said, 'In the fourth quarter, rural markets continued to outpace urban consumption with rural demand growing ahead of urban India by 350bps. That said, the gap between rural and urban growth has narrowed significantly compared to December 2025, reflecting a more balanced consumption recovery. We expect this convergence to continue. Within Urban India, e-commerce and Modern Trade have been driving demand, growing by 49% and 19% respectively. Quick Commerce is driving the online business, posting a growth of 54%. This channel was a major contributor to our foods business, which grew by 30% in Q4. We will continue to double down on emerging channels, which serve as the incubators for Dabur's innovation and premium products. As part of this initiative, we have launched SIENS, Dabur's first online only Direct-to-Consumer nutraceutical brand, which is showing great consumer traction. We continue to invest heavily behind this brand,' Meanwhile, the company's board recommended a final dividend of Rs 5.50 per equity share having face value of Re 1 each for the financial year 2025-26. The record date has been fixed as July 17 2026. Dabur India is one of India's leading FMCG companies. The company manufactures personal care, healthcare and food products. Its portfolio includes eight major power brands- Dabur Chyawanprash, Dabur Honey, Honitus, PudinHara and Dabur Lal Tail in the healthcare catrogory, Dabur Amla and Dabur Red Paste in the personal care and Real in the food & beverages space. The counter rose 0.79% to settle at Rs 470.05 on the BSE.Powered by Capital Market - Live

Dabur India announced that the Board of Directors of the Company at its meeting held on 7 May 2026, inter alia, have recommended the final dividend of Rs 5.5 per equity Share (i.e. 550%) , subject to the approval of the shareholders.